|
|
|
Volumn 57, Issue 1, 2002, Pages 3-9
|
|
Cost-of-illness of lung disease in the TriVeneto Region, Italy: The GOLD study
a
|
|
Author keywords
Asthma; COPD, community acquired pneumonia; Cost of illness; Pharmacoeconomics
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BRONCHODILATING AGENT;
STEROID;
ADOLESCENT;
ADULT;
ARTICLE;
ASTHMA;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CLINICAL OBSERVATION;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
COMPUTER PROGRAM;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST OF ILLNESS;
DATA BASE;
DIAGNOSTIC ERROR;
DISEASE SEVERITY;
EARLY DIAGNOSIS;
FEMALE;
FOLLOW UP;
HUMAN;
ITALY;
LOWER RESPIRATORY TRACT;
LUNG DISEASE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RESEARCH;
MULTICENTER STUDY;
NATIONAL HEALTH SERVICE;
OUTCOMES RESEARCH;
PNEUMONIA;
RANDOMIZED CONTROLLED TRIAL;
RESOURCE ALLOCATION;
RISK FACTOR;
|
|
EID: 14244270496
PISSN: 11220643
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (53)
|
|
References (23)
|
